Steven Bai
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Blood Coagulation and Thrombosis Mechanisms, Atrial Fibrillation Management and Outcomes, EEG and Brain-Computer Interfaces, Heart Rate Variability and Autonomic Control, Cardiovascular Syncope and Autonomic Disorders
Most-Cited Works
- → Aging Increases Pharmacodynamic Sensitivity to the Hypnotic Effects of Midazolam(1995)124 cited
- → Midazolam and fentanyl continuous infusion anesthesia for cardiac surgery: comparison of computer-assisted versus manual infusion systems(1993)76 cited
- → Discovery of 1-(2-Aminomethylphenyl)-3-trifluoromethyl-N- [3-fluoro-2‘-(aminosulfonyl)[1,1‘-biphenyl)]-4-yl]-1H-pyrazole-5-carboxyamide (DPC602), a Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor(2003)75 cited
- → 1-[3-Aminobenzisoxazol-5′-yl]-3-trifluoromethyl-6-[2′-(3-(R)-hydroxy-N-pyrrolidinyl)methyl-[1,1′]-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa(2006)63 cited
- → Synthesis and Structure−Activity Relationships of 8-(Pyrid-3-yl)pyrazolo[1,5-a]-1,3,5-triazines: Potent, Orally Bioavailable Corticotropin Releasing Factor Receptor-1 (CRF1) Antagonists(2009)58 cited
- → Structure–activity relationship and pharmacokinetic profile of 5-ketopyrazole factor Xa inhibitors(2007)36 cited
- → Design, structure–activity relationship, and pharmacokinetic profile of pyrazole-based indoline factor Xa inhibitors(2007)21 cited